| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to accelerate an end to human rabies deaths
|
Thumbi, S M
|
|
|
400 |
10369 |
p. 2261-2264
|
artikel
|
| 2 |
A new cholinergic mechanism for antipsychotics: emraclidine and M4 muscarinic receptors
|
Cookson, John
|
|
|
400 |
10369 |
p. 2159-2161
|
artikel
|
| 3 |
Bacterial pathogens and climate change
|
Gona, Philimon N
|
|
|
400 |
10369 |
p. 2161-2163
|
artikel
|
| 4 |
Building on Pasteur's legacy: producing vaccines in Africa
|
Karim, Salim S Abdool
|
|
|
400 |
10369 |
p. 2164-2166
|
artikel
|
| 5 |
Department of Error
|
|
|
|
400 |
10369 |
p. 2198
|
artikel
|
| 6 |
Directly observed therapy
|
Papineni, Padmasayee
|
|
|
400 |
10369 |
p. 2265-2266
|
artikel
|
| 7 |
Elsevier must end its fossil fuel partnerships and subsidies
|
Macmillan, Alex
|
|
|
400 |
10369 |
p. 2193
|
artikel
|
| 8 |
Elsevier must end its fossil fuel partnerships and subsidies – Publisher's reply
|
Erkal, Esra
|
|
|
400 |
10369 |
p. 2193
|
artikel
|
| 9 |
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
|
Krystal, John H
|
|
|
400 |
10369 |
p. 2210-2220
|
artikel
|
| 10 |
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
400 |
10369 |
p. 2221-2248
|
artikel
|
| 11 |
Highlights 2022: sharpening the focus on powerful health stories
|
Palmer, Joanna
|
|
|
400 |
10369 |
p. 2179-2192
|
artikel
|
| 12 |
Innovation for infection prevention and control—revisiting Pasteur's vision
|
Birgand, Gabriel
|
|
|
400 |
10369 |
p. 2250-2260
|
artikel
|
| 13 |
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
|
Kalra, Paul R
|
|
|
400 |
10369 |
p. 2199-2209
|
artikel
|
| 14 |
Intravenous iron passes another endurance test in heart failure
|
McDonagh, Theresa A
|
|
|
400 |
10369 |
p. 2158-2159
|
artikel
|
| 15 |
Louis Pasteur, COVID-19, and the social challenges of epidemics
|
Giles-Vernick, Tamara
|
|
|
400 |
10369 |
p. 2166-2168
|
artikel
|
| 16 |
Louis Pasteur's public engagement
|
Löwy, Ilana
|
|
|
400 |
10369 |
p. 2176-2178
|
artikel
|
| 17 |
Modest health goals for new US Congress
|
Jaffe, Susan
|
|
|
400 |
10369 |
p. 2172-2173
|
artikel
|
| 18 |
Monkeypox as a PHEIC: implications for global health governance
|
Wenham, Clare
|
|
|
400 |
10369 |
p. 2169-2171
|
artikel
|
| 19 |
Pasteur's legacy in 21st century medicine
|
The Lancet,
|
|
|
400 |
10369 |
p. 2157
|
artikel
|
| 20 |
Recurrent rectal bleeding in a teenager caused by a cavernous haemangioma of the sigmoid colon
|
González, Marta Martín
|
|
|
400 |
10369 |
p. 2249
|
artikel
|
| 21 |
Research focus: Pasteur Institute of Dakar
|
Burki, Talha
|
|
|
400 |
10369 |
p. 2174-2175
|
artikel
|
| 22 |
Science knows no country: fulfilling Louis Pasteur's legacy
|
Grais, Rebecca F
|
|
|
400 |
10369 |
p. 2163-2164
|
artikel
|
| 23 |
WHO Living Guidelines on antivirals for COVID-19 are evidence-based
|
Owen, Andrew
|
|
|
400 |
10369 |
p. 2196-2198
|
artikel
|
| 24 |
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
|
Wu, Mary Y
|
|
|
400 |
10369 |
p. 2193-2196
|
artikel
|
| 25 |
Winner of the 2022 Wakley Prize: compassion and connection
|
Bagenal, Jessamy
|
|
|
400 |
10369 |
p. 2171
|
artikel
|
Tijdschrift beschrijving